New Jersey 2026-2027 Regular Session

New Jersey Assembly Bill A626

Introduced
1/13/26  

Caption

Increases access to substance use disorder treatment; Requires Medicaid coverage for substance use disorder services provided by community-based organizations.

Impact

The introduction of A626 is expected to have significant implications for state laws regarding substance use disorder treatment. By establishing such mandates, the bill aligns with efforts to address the ongoing opioid crisis and improve healthcare access for those struggling with addiction. Supporters argue that the bill represents a necessary shift towards integrating community-based organizations into the formal treatment infrastructure, potentially leading to improved patient outcomes and greater engagement in recovery programs. Additionally, the bill aims to clarify the roles and responsibilities of opioid treatment programs and medication units in the treatment process.

Summary

Assembly Bill A626 aims to expand access to substance use disorder treatment by mandating Medicaid coverage for services provided by licensed community-based organizations. The bill seeks to enhance the availability of treatment options, particularly for opioid use disorders, emphasizing the establishment of medication units associated with opioid treatment programs. These medication units are designed to provide a range of services, including psychosocial assessments and the initiation of medication-assisted treatment, which may include drugs like methadone and buprenorphine. Moreover, the bill allows for the provision of telecounseling services, expanding treatment possibilities for patients who may face barriers in attending in-person sessions.

Contention

Despite its potential benefits, the bill may encounter opposition from various stakeholders concerned about the implementation details and funding implications for state Medicaid programs. Key points of contention may arise around the extent of the services covered, as well as the adequacy of funding required to support increased demand for services. Care providers and community organizations may also express concerns regarding the regulatory framework surrounding community-based organizations and their capacity to meet demand effectively, raising questions about quality control and patient safety.

Companion Bills

NJ S4043

Carry Over Increases access to substance use disorder treatment; Requires Medicaid coverage for substance use disorder services provided by community-based organizations.

NJ A5354

Carry Over Increases access to substance use disorder treatment; Requires Medicaid coverage for substance use disorder services provided by community-based organizations.

NJ S2492

Same As Increases access to substance use disorder treatment; Requires Medicaid coverage for substance use disorder services provided by community-based organizations.

Similar Bills

AZ HB2944

Inpatient treatment days; computation; exclusion

AZ SB1244

Court-ordered treatment; continuation

CA AB1879

Substance use: treatment or residential data reporting.

AZ HB2706

Mental health; intensive treatment orders

CA AB2538

Medi-Cal: hospice providers: forms.

IA HF326

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)

IA HF518

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)

HI SB2292

Relating To Workers' Compensation Medical Treatment.